Coco Nucleus India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-01-2025
- Paid Up Capital ₹ 0.10 M
as on 01-01-2025
- Company Age 4 Year, 27 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 16.83%
(FY 2022)
- Ebitda -1160.83%
(FY 2022)
- Net Worth -4829.18%
(FY 2022)
- Total Assets 3814.64%
(FY 2022)
About Coco Nucleus India
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gadabanahalli Deepika and Punith Swamy serve as directors at the Company.
- CIN/LLPIN
U15400KA2020PTC142178
- Company No.
142178
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Coco Nucleus India Private Limited offer?
Coco Nucleus India Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Churna and Goli.
Who are the key members and board of directors at Coco Nucleus India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gadabanahalli Deepika  | Director | 14-Dec-2020 | Current |
| Punith Swamy | Director | 14-Dec-2020 | Current |
Financial Performance of Coco Nucleus India.
Coco Nucleus India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 16.83% increase in profit. The company's net worth observed a substantial decline by a decrease of 4829.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Coco Nucleus India?
Unlock access to Coco Nucleus India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Coco Nucleus India?
Coco Nucleus India has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Coco Nucleus India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coco Nucleus India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
